Fintech

Clearmind Medicine Granted U.S. Patent for Binge Behavior Regulators

Globenewswire·June 18, 2026 at 11:55 AM

Vancouver, Canada, June 18, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the “Company”), a clinical-stage biotech...

Original Source

Globenewswire — www.globenewswire.com

Related in Fintech

Deutsche Bank Sees Proven AI Investment Returns
PYMNTS
Banking Groups Urge Basel Proposal Changes
PYMNTS
Senate Bill Targets AI Firms Ownership
PYMNTS
AI, Digital Money Face Business Case Test
PYMNTS

Clearmind Medicine Granted U.S. Patent for Binge Behavior Regulators

Deutsche Bank Sees Proven AI Investment Returns

Banking Groups Urge Basel Proposal Changes

Senate Bill Targets AI Firms Ownership

AI, Digital Money Face Business Case Test